Physician profile
Xi Chen
NPI 1043570674
$1,240.40
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $794 · 2020: $84.44 · 2021: $20.14 · 2022: $255 · 2024: $86.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $575.35 | 2019 | |
| Abbott Laboratories | $238.97 | 2022 | |
| Neuronetics, INC. | $86.97 | 2024 | Neurostar Tms Therapy System |
| Boston Scientific Corporation | $73.56 | 2019 | |
| Mdd US Operations, LLC | $62.37 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $42.54 | 2019-2020 | |
| Stimwave Technologies Incorporated | $31.93 | 2019-2020 | |
| Si-Bone, INC. | $30.52 | 2019 | |
| Allergan, INC. | $20.14 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.87 | 2019 | |
| Biodelivery Sciences International, INC. | $17.10 | 2020 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.55 | 2022 | |
| Medtronic USA, INC. | $13.82 | 2019 | |
| Lilly USA, LLC | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xi Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.